Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-08

Clinical Trial Update: Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing effects of glucose-lowering agents in South Asian women with impaired glucose tolerance or impaired fasting glucose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oslo University Hospital | Conditions: Impaired Glucose Tolerance, Insulin Sensitivity | Phase 2 | Status: UNKNOWN